Emend (aprepitant) 3 caps. MSD, Ireland
Article:
M-8
In Stock
testimony
As part of combination therapy:
prevention of acute and delayed nausea and vomiting associated with cisplatin-based anticancer chemotherapy with a high emetogenic risk in adults,
prevention of nausea and vomiting associated with the use of anti-cancer chemotherapy with a moderate emetogenic risk in adults.
Mistakes in spelling emend, emind, emind.
-
Commercial name:Emend
-
Сhemical name:aprepitant
-
Quantity:3
-
Release form:Capsules
-
Виробник:MSD
No reviews yet